|
1
|
Niessen FB, Spauwen PH, Schalkwijk J and
Kon M: On the nature of hypertrophic scars and keloids: A review.
Plast Reconstr Surg. 104:1435–1458. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Werner S and Grose R: Regulation of wound
healing by growth factors and cytokines. Physiol Rev. 83:835–870.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berman B, Viera MH, Amini S, Huo R and
Jones IS: Prevention and management of hypertrophic scars and
keloids after burns in children. J Craniofac Surg. 19:989–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Menke MN, Menke NB, Boardman CH and
Diegelmann RF: Biologic therapeutics and molecular profiling to
optimize wound healing. Gynecol Oncol. 111 2 Suppl:S87–S91. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Younai S, Venters G, Vu S, Nichter L,
Nimni ME and Tuan TL: Role of growth factors in scar contraction:
An in vitro analysis. Ann Plast Surg. 36:495–501. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilgus TA, Ferreira AM, Oberyszyn TM,
Bergdall VK and Dipietro LA: Regulation of scar formation by
vascular endothelial growth factor. Lab Invest. 88:579–590. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grella A, Kole D, Holmes W and Dominko T:
FGF2 overrides TGFβ1-driven integrin ITGA11 expression in human
dermal fibroblasts. J Cell Biochem. 117:1000–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferguson MW and O'Kane S: Scar-free
healing: From embryonic mechanisms to adult therapeutic
intervention. Philos Trans R Soc Lond B Biol Sci. 359:839–850.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reish RG and Eriksson E: Scar treatments:
Preclinical and clinical studies. J Am Coll Surg. 206:719–730.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mofikoya BO, Adeyemo WL and Abdus-salam
AA: Keloid and hypertrophic scars: A review of recent developments
in pathogenesis and management. Nig Q J Hosp Med. 17:134–139.
2007.PubMed/NCBI
|
|
11
|
Leventhal D, Furr M and Reiter D:
Treatment of keloids and hypertrophic scars: A meta-analysis and
review of the literature. Arch Facial Plast Surg. 8:362–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Janda K, Krzanowski M, Dumnicka P,
Kuśnierz-Cabala B, Kraśniak A and Sułowicz W: Transforming growth
factor beta 1 as a risk factor for cardiovascular diseases in
end-stage renal disease patients treated with peritoneal dialysis.
Clin Lab. 60:1163–1168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Massagué J: Wounding Smad. Nat Cell Biol.
1:E117–E119. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Wang DR and Cao YL: TGF-beta: A
fibrotic factor in wound scarring and a potential target for
anti-scarring gene therapy. Curr Gene Ther. 4:123–136. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ashcroft GS, Yang X, Glick AB, Weinstein
M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng
C and Roberts AB: Mice lacking Smad3 show accelerated wound healing
and an impaired local inflammatory response. Nat Cell Biol.
1:260–266. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou M, Wang F, Gao R, Wu J, Ou Y, Chen X,
Wang T, Zhou X, Zhu W, Li P, et al: Autophagy inhibition of
hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced
fibrogenesis in human cardiac fibroblasts. Sci Rep. 6:247472016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Correia AC, Moonen JR, Brinker MG and
Krenning G: FGF2 inhibits endothelial-mesenchymal transition
through microRNA-20a-mediated repression of canonical TGF-β
signaling. J Cell Sci. 129:569–579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Q, Cheng Q, Chen Z, Peng R, Chen R, Ma
Z, Wan X, Liu J, Meng M, Peng Z and Jiang B: MicroRNA-663 inhibits
the proliferation, migration and invasion of glioblastoma cells via
targeting TGF-β1. Oncol Rep. 35:1125–1134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Liu J, Fan L, Wang F, Yu H, Wei W
and Sun G: miR-663 overexpression induced by endoplasmic reticulum
stress modulates hepatocellular carcinoma cell apoptosis via
transforming growth factor beta 1. Onco Targets Ther. 9:1623–1633.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van de Kar AL, Corion LU, Smeulders MJ,
Draaijers LJ, van der Horst CM and van Zuijlen PP: Reliable and
feasible evaluation of linear scars by the patient and observer
Scar assessment scale. Plast Reconstr Surg. 116:514–522. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoogewerf CJ, van Baar ME, Middelkoop E
and van Loey NE: Patient reported facial scar assessment:
Directions for the professional. Burns. 40:347–353. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen
T, Chen Z, Huang S, Gu J, Li J, et al: MiR-199a-5p is negatively
associated with malignancies and regulates glycolysis and lactate
production by targeting hexokinase 2 in liver cancer. Hepatology.
62:1132–1144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gorney M: Scar: The trigger to the claim.
Plast Reconstr Surg. 117:1036–1037. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong F, Wu N, Ge Y, Zhou Y, Shen T, Qiang
Q, Zhang Q, Chen M, Wang Y, Wang L and Hong J: Nanosized titanium
dioxide resulted in the activation of TGF-β/Smads/p38MAPK pathway
in renal inflammation and fibration of mice. J Biomed Mater Res A.
104:1452–1461. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou B, Zeng S, Li L, Fan Z, Tian W, Li M,
Xu H, Wu X, Fang M and Xu Y: Angiogenic factor with G patch and FHA
domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β
signaling. Biochim Biophys Acta. 1862:1203–1213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Colwell AS, Longaker MT and Lorenz HP:
Fetal wound healing. Front Biosci. 8:s1240–s1248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colwell AS, Longaker MT and Lorenz HP:
Mammalian fetal organ regeneration. Adv Biochem Eng Biotechnol.
93:83–100. 2005.PubMed/NCBI
|
|
29
|
Gurtner GC, Werner S, Barrandon Y and
Longaker MT: Wound repair and regeneration. Nature. 453:314–321.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beanes SR, Dang C, Soo C, Wang Y, Urata M,
Ting K, Fonkalsrud EW, Benhaim P, Hedrick MH, Atkinson JB and
Lorenz HP: Down-regulation of decorin, a transforming growth
factor-beta modulator, is associated with scarless fetal wound
healing. J Pediatr Surg. 36:1666–1671. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi Y, Ye K, Wu H, Sun Y, Shi H and Huo K:
Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting
with NLK. Mol Cell Biochem. 333:293–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li
H and Du J: The Notch γ-secretase inhibitor ameliorates kidney
fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway
activation. Int J Biochem Cell Biol. 55:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hong Q, Yu S, Geng X, Duan L, Zheng W, Fan
M, Chen X and Wu D: High concentrations of uric acid inhibit
endothelial cell migration via miR-663 which regulates phosphatase
and tensin homolog by targeting transforming growth factor-β1.
Microcirculation. 22:306–314. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu W, Xu S, Yao B, Hong M, Wu X, Pei H,
Chang L, Ding N, Gao X, Ye C, et al: MiR-663 inhibits
radiation-induced bystander effects by targeting TGFB1 in a
feedback mode. RNA Biol. 11:1189–1198. 2014. View Article : Google Scholar : PubMed/NCBI
|
